A 6000% price rise in ten years? Big corporations overcharge for your medicine and rip off the NHS.

NHS Not Safe
Mark Turley

The Competition and Markets Authority (CMA) has ruled that Canadian pharmaceutical company Concordia has effectively been ripping off the NHS. Since 2007, Concordia has raised the price of a life-changing drug, for which it was the only supplier, by 6000%. The CMA’s ruling therefore raises deeper questions about the role of the marketplace in our public services.

Lack of competition

Until last year, Concordia was the only global supplier of Liothryronine, a drug used to treat hypothyroidism. Usually affecting those over the age of 40, the symptoms of hypothyroidism can be debilitating. They include weight gain, breathlessness and mobility issues.

When Concordia first sold its treatment to the NHS, in 2007, it cost £4.46 a pack. By 2017, this had increased to a staggering £258.19. For a single tablet, this equated to a rise from 16p to £9.22. Yet the cost of producing the drug remained broadly the same during that period.

CMA Chief Executive Andrea Coscelli said:

Pharmaceutical companies which abuse their position and overcharge for drugs are forcing the NHS – and the UK taxpayer – to pay over the odds for important medical treatments. We allege that Concordia used its market dominance in the supply of Liothyronine tablets to do exactly that.

Nothing new…

The practice is nothing new for companies like Concordia. In October 2016, its CEO Mark Thompson resigned amid accusations of “aggressive price hiking”. In the past, giant US firms like Pfizer and Flynn Pharma provoked similar scandals. British company GlaxoSmithKline was fined heavily for market rigging in January 2016. Such companies wield huge power. Against that, the underfunded and asset-stripped NHS can do little to protect itself, or its patients.

A wrong-headed approach?

The CMA judgement is welcome, but provides no long-term solutions, as big companies will continue to abuse their position. Pharmaceutical corporations, like all corporations, aim solely to maximise profit for shareholders. This is the prevailing system. But it is not a sensible approach to healthcare.

Public services should be run for people, not profit.

Get Involved!

– Read more Canary stories about the NHS here.

Join us so we can continue to hold the powerful to account.

Featured image via Flickr

We need your help ...

The coronavirus pandemic is changing our world, fast. And we will do all we can to keep bringing you news and analysis throughout. But we are worried about maintaining enough income to pay our staff and minimal overheads.

Now, more than ever, we need a vibrant, independent media that holds the government to account and calls it out when it puts vested economic interests above human lives. We need a media that shows solidarity with the people most affected by the crisis – and one that can help to build a world based on collaboration and compassion.

We have been fighting against an establishment that is trying to shut us down. And like most independent media, we don’t have the deep pockets of investors to call on to bail us out.

Can you help by chipping in a few pounds each month?

The Canary Support us

Comments are closed